DGX Stock News & Catalysts – Quest Diagnostics

FEATURED

Quest Diagnostics to Speak at the 9th Annual Evercore Healthcare Conference

New

SECAUCUS, N.J., Nov. 9, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE:DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will

Summary

Nov 9, 2026, 12:40 PM ·PRNewswire

RECENT

Quest Diagnostics to Speak at the Jefferies Global Healthcare Conference in London

New

Nov 9, 2026, 12:39 PM ·PRNewswire

Quest Diagnostics Reports Third Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

Third quarter revenues of $3.10 billion, up 10.0% from 2025, on strong organic revenue growthThird quarter reported diluted earnings per share ("EPS") of $2.78, up 28.7% from 2025; and adjusted diluted EPS of

Oct 22, 2026, 6:46 AM ·PRNewswire

Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option

Expands access to most comprehensive FDA-approved HPV test and at-home self-collection option across Quest's national clinician, health plan, and consumer channels starting in 2027First and only FDA-approved HPV

Oct 20, 2026, 8:00 AM ·PRNewswire

Current Screening Thresholds May Miss Half of Patients with Primary Aldosterone, a Leading Cause of Severe High Blood Pressure, Finds Study in Hypertension

Half of patients with the hormonal disorder, which raises risk of heart attack, stroke and kidney disease, may be undiagnosed under current screening thresholds SECAUCUS, N.J., Oct. 19, 2026 /PRNewswire/ -- A new study

Oct 19, 2026, 7:57 AM ·PRNewswire

Haystack MRD® Demonstrates Robust Clinical Performance in Specimen Cohort from the Landmark DYNAMIC Colorectal Cancer Trials

Test showed 100% specificity, with no false-positive results in the cohort, at both 3- and 5-year follow-up, and sensitivity of 100% and 83.3%, respectively, for predicting disease recurrence SECAUCUS, N.J., Oct. 1,

Oct 1, 2026, 8:52 AM ·PRNewswire

Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026

SECAUCUS, N.J., Sept. 22, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE:DGX), a leader in diagnostic information services, announced today that it will report its third quarter 2026 financial results on

Sep 22, 2026, 4:28 PM ·PRNewswire

Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics

Study published in JAMA Network Open of over 193,000 patients nationwide reveals that individuals with evidence of exposure to Borrelia burgdorferi, the bacterium that causes Lyme disease, are more than four times as

Sep 21, 2026, 8:03 AM ·PRNewswire

Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics

75% of registered voters surveyed call diagnostic testing "very important" to their care, and a bipartisan majority wants Congress to pass the RESULTS Act before additional Medicare cuts are scheduled to take

Sep 16, 2026, 8:03 AM ·PRNewswire

Apple Health app Users to be Able to Order Labs from Quest Diagnostics

Coming later this year, Apple Health app users will be able to conveniently and securely purchase and receive results of Quest's biomarker lab testing directly in the appSECAUCUS, N.J., Sept. 9, 2026 /PRNewswire/ --

Sep 9, 2026, 4:01 PM ·PRNewswire

Quest Diagnostics to Speak at the Baird 2026 Global Healthcare Conference

SECAUCUS, N.J., Aug. 25, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE:DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the

Aug 25, 2026, 9:30 AM ·PRNewswire

Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com

Individuals in the U.S. can now add Humanity Biological Age's lab-informed insights to select health profile tests purchased through Quest's consumer-initiated testing platformLONDON, Aug. 25, 2026 /PRNewswire/

Aug 25, 2026, 8:00 AM ·PRNewswire

Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference

SECAUCUS, N.J., Aug. 24, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE:DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President & Chief Financial Officer,

Aug 24, 2026, 9:00 AM ·PRNewswire

Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease Pathology

Test to join the company's expansive portfolio of Quest AD-Detect® blood tests for assessing symptomatic patients Quest also launching a new multi-biomarker AD-Detect® lab-developed blood test with low 10%

Aug 24, 2026, 7:24 AM ·PRNewswire

WHOOP Makes Advanced Labs Available Without a Wearable Membership

WHOOP Advanced Labs is now available without a WHOOP membership and includes Galleri®, GRAIL's multi-cancer early detection test. WHOOP, the human performance brand, today announced it is expanding access to

Aug 18, 2026, 9:00 AM ·Business Wire

Quest Diagnostics Incorporated DGX · News